Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

The incremental shuttle walk test predicts mortality in non-group 1 pulmonary hypertension: results from the ASPIRE Registry.

Billings CG, Lewis R, Hurdman JA, Condliffe R, Elliot CA, Thompson AAR, Smith IA, Austin M, Armstrong IJ, Hamilton N, Charalampopoulos A, Sabroe I, Swift AJ, Rothman AM, Wild JM, Lawrie A, Waterhouse JC, Kiely DG.

Pulm Circ. 2019 Apr-Jun;9(2):2045894019848649. doi: 10.1177/2045894019848649.

2.

The impact of patient choice on survival in chronic thromboembolic pulmonary hypertension.

Quadery SR, Swift AJ, Billings CG, Thompson AAR, Elliot CA, Hurdman J, Charalampopoulos A, Sabroe I, Armstrong IJ, Hamilton N, Sephton P, Garrad S, Pepke-Zaba J, Jenkins DP, Screaton N, Rothman AM, Lawrie A, Cleveland T, Thomas S, Rajaram S, Hill C, Davies C, Johns CS, Wild JM, Condliffe R, Kiely DG.

Eur Respir J. 2018 Sep 16;52(3). pii: 1800589. doi: 10.1183/13993003.00589-2018. Print 2018 Sep.

3.

Incremental Shuttle Walking Test Distance Is Reduced in Patients With Pulmonary Hypertension in World Health Organisation Functional Class I.

Billings CG, Lewis R, Armstrong IJ, Hurdman JA, Smith IA, Austin M, Elliot CA, Charalampopoulos A, Sabroe I, Lawrie A, Thompson AAR, Condliffe R, Kiely DG.

Front Med (Lausanne). 2018 Jun 21;5:172. doi: 10.3389/fmed.2018.00172. eCollection 2018.

4.

Kombucha: is a cup of tea good for you?

Holbourn A, Hurdman J.

BMJ Case Rep. 2017 Dec 2;2017. pii: bcr-2017-221702. doi: 10.1136/bcr-2017-221702.

PMID:
29197835
5.

Incremental shuttle walk test distance and autonomic dysfunction predict survival in pulmonary arterial hypertension.

Billings CG, Hurdman JA, Condliffe R, Elliot CA, Smith IA, Austin M, Armstrong IJ, Hamilton N, Charalampopoulos A, Sabroe I, Swift AJ, Rothman AM, Wild JM, Lawrie A, Waterhouse JC, Kiely DG.

J Heart Lung Transplant. 2017 Aug;36(8):871-879. doi: 10.1016/j.healun.2017.04.008. Epub 2017 Apr 24.

6.

Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes.

Ramjug S, Hussain N, Hurdman J, Billings C, Charalampopoulos A, Elliot CA, Kiely DG, Sabroe I, Rajaram S, Swift AJ, Condliffe R.

Chest. 2017 Jul;152(1):92-102. doi: 10.1016/j.chest.2017.02.010. Epub 2017 Feb 20.

PMID:
28223154
7.

Long-term outcomes of domiciliary intravenous iloprost in idiopathic and connective tissue disease-associated pulmonary arterial hypertension.

Ramjug S, Hussain N, Hurdman J, Elliot CA, Sabroe I, Armstrong IJ, Billings C, Hamilton N, Kiely DG, Condliffe R.

Respirology. 2017 Feb;22(2):372-377. doi: 10.1111/resp.12899. Epub 2016 Sep 20.

PMID:
27651181
8.

Pulmonary arterial hypertension associated with congenital heart disease: Comparison of clinical and anatomic-pathophysiologic classification.

Ramjug S, Hussain N, Hurdman J, Billings C, Charalampopoulos A, Elliot CA, Sabroe I, Kiely DG, Condliffe R.

J Heart Lung Transplant. 2016 May;35(5):610-8. doi: 10.1016/j.healun.2015.12.016. Epub 2016 Jan 7.

PMID:
26880324
9.

Management of acute pulmonary embolism.

Quadery R, Elliot CA, Hurdman J, Kiely DG, Maclean RM, Sabroe I, van Veen JJ, Condliffe R.

Br J Hosp Med (Lond). 2015 Oct;76(10):C150-5. doi: 10.12968/hmed.2015.76.10.C150. No abstract available.

PMID:
26457952
10.

CT features of pulmonary arterial hypertension and its major subtypes: a systematic CT evaluation of 292 patients from the ASPIRE Registry.

Rajaram S, Swift AJ, Condliffe R, Johns C, Elliot CA, Hill C, Davies C, Hurdman J, Sabroe I, Wild JM, Kiely DG.

Thorax. 2015 Apr;70(4):382-7. doi: 10.1136/thoraxjnl-2014-206088. Epub 2014 Dec 18.

11.

Magnetic resonance imaging of ventilation and perfusion changes in response to pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension.

Marshall H, Kiely DG, Parra-Robles J, Capener D, Deppe MH, van Beek EJ, Swift AJ, Rajaram S, Hurdman J, Condliffe R, Elliot CA, Wild JM.

Am J Respir Crit Care Med. 2014 Sep 1;190(5):e18-9. doi: 10.1164/rccm.201310-1842IM. No abstract available.

12.

Dynamic contrast-enhanced magnetic resonance imaging in patients with pulmonary arterial hypertension.

Swift AJ, Telfer A, Rajaram S, Condliffe R, Marshall H, Capener D, Hurdman J, Elliot C, Kiely DG, Wild JM.

Pulm Circ. 2014 Mar;4(1):61-70. doi: 10.1086/674882.

13.

Ambrisentan therapy in pulmonary hypertension: clinical use and tolerability in a referral centre.

Condliffe R, Elliot CA, Hurdman J, Sabroe I, Billings C, Kiely DG, Hamilton N.

Ther Adv Respir Dis. 2014 Jun;8(3):71-77. Epub 2014 Apr 30.

PMID:
24787237
14.

Management dilemmas in acute pulmonary embolism.

Condliffe R, Elliot CA, Hughes RJ, Hurdman J, Maclean RM, Sabroe I, van Veen JJ, Kiely DG.

Thorax. 2014 Feb;69(2):174-80. doi: 10.1136/thoraxjnl-2013-204667. Epub 2013 Dec 16. Review.

15.

Prognostic value of cardiovascular magnetic resonance imaging measurements corrected for age and sex in idiopathic pulmonary arterial hypertension.

Swift AJ, Rajaram S, Campbell MJ, Hurdman J, Thomas S, Capener D, Elliot C, Condliffe R, Wild JM, Kiely DG.

Circ Cardiovasc Imaging. 2014 Jan;7(1):100-6. doi: 10.1161/CIRCIMAGING.113.000338. Epub 2013 Nov 25.

PMID:
24275955
16.

Noninvasive estimation of PA pressure, flow, and resistance with CMR imaging: derivation and prospective validation study from the ASPIRE registry.

Swift AJ, Rajaram S, Hurdman J, Hill C, Davies C, Sproson TW, Morton AC, Capener D, Elliot C, Condliffe R, Wild JM, Kiely DG.

JACC Cardiovasc Imaging. 2013 Oct;6(10):1036-1047. doi: 10.1016/j.jcmg.2013.01.013. Epub 2013 Jun 13.

17.

Central venous catheter-related blood stream infections in patients receiving intravenous iloprost for pulmonary hypertension.

Sammut D, Elliot CA, Kiely DG, Armstrong IJ, Martin L, Wilkinson J, Sephton P, Jones J, Hamilton N, Hurdman J, McLellan E, Sabroe I, Condliffe R.

Eur J Clin Microbiol Infect Dis. 2013 Jul;32(7):883-9. doi: 10.1007/s10096-013-1822-z. Epub 2013 Feb 7.

PMID:
23388830
18.

3D contrast-enhanced lung perfusion MRI is an effective screening tool for chronic thromboembolic pulmonary hypertension: results from the ASPIRE Registry.

Rajaram S, Swift AJ, Telfer A, Hurdman J, Marshall H, Lorenz E, Capener D, Davies C, Hill C, Elliot C, Condliffe R, Wild JM, Kiely DG.

Thorax. 2013 Jul;68(7):677-8. doi: 10.1136/thoraxjnl-2012-203020. Epub 2013 Jan 24.

PMID:
23349220
19.

Pulmonary hypertension in COPD: results from the ASPIRE registry.

Hurdman J, Condliffe R, Elliot CA, Swift A, Rajaram S, Davies C, Hill C, Hamilton N, Armstrong IJ, Billings C, Pollard L, Wild JM, Lawrie A, Lawson R, Sabroe I, Kiely DG.

Eur Respir J. 2013 Jun;41(6):1292-301. doi: 10.1183/09031936.00079512. Epub 2012 Sep 27.

20.

Pulmonary artery relative area change detects mild elevations in pulmonary vascular resistance and predicts adverse outcome in pulmonary hypertension.

Swift AJ, Rajaram S, Condliffe R, Capener D, Hurdman J, Elliot C, Kiely DG, Wild JM.

Invest Radiol. 2012 Oct;47(10):571-7. doi: 10.1097/RLI.0b013e31826c4341.

PMID:
22914228
21.

Diagnostic accuracy of cardiovascular magnetic resonance imaging of right ventricular morphology and function in the assessment of suspected pulmonary hypertension results from the ASPIRE registry.

Swift AJ, Rajaram S, Condliffe R, Capener D, Hurdman J, Elliot CA, Wild JM, Kiely DG.

J Cardiovasc Magn Reson. 2012 Jun 21;14:40. doi: 10.1186/1532-429X-14-40.

22.

Comparison of the diagnostic utility of cardiac magnetic resonance imaging, computed tomography, and echocardiography in assessment of suspected pulmonary arterial hypertension in patients with connective tissue disease.

Rajaram S, Swift AJ, Capener D, Elliot CA, Condliffe R, Davies C, Hill C, Hurdman J, Kidling R, Akil M, Wild JM, Kiely DG.

J Rheumatol. 2012 Jun;39(6):1265-74. doi: 10.3899/jrheum.110987. Epub 2012 May 15.

PMID:
22589263
23.

Lung morphology assessment with balanced steady-state free precession MR imaging compared with CT.

Rajaram S, Swift AJ, Capener D, Telfer A, Davies C, Hill C, Condliffe R, Elliot C, Hurdman J, Kiely DG, Wild JM.

Radiology. 2012 May;263(2):569-77. doi: 10.1148/radiol.12110990. Epub 2012 Mar 6.

PMID:
22396606
24.

Black blood MRI has diagnostic and prognostic value in the assessment of patients with pulmonary hypertension.

Swift AJ, Rajaram S, Marshall H, Condliffe R, Capener D, Hill C, Davies C, Hurdman J, Elliot CA, Wild JM, Kiely DG.

Eur Radiol. 2012 Mar;22(3):695-702. doi: 10.1007/s00330-011-2306-0. Epub 2011 Oct 13.

PMID:
21993983
25.

Diagnostic accuracy of contrast-enhanced MR angiography and unenhanced proton MR imaging compared with CT pulmonary angiography in chronic thromboembolic pulmonary hypertension.

Rajaram S, Swift AJ, Capener D, Telfer A, Davies C, Hill C, Condliffe R, Elliot C, Hurdman J, Kiely DG, Wild JM.

Eur Radiol. 2012 Feb;22(2):310-7. doi: 10.1007/s00330-011-2252-x. Epub 2011 Sep 2.

PMID:
21887483
26.

ASPIRE registry: assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre.

Hurdman J, Condliffe R, Elliot CA, Davies C, Hill C, Wild JM, Capener D, Sephton P, Hamilton N, Armstrong IJ, Billings C, Lawrie A, Sabroe I, Akil M, O'Toole L, Kiely DG.

Eur Respir J. 2012 Apr;39(4):945-55. doi: 10.1183/09031936.00078411. Epub 2011 Sep 1.

27.

CT pulmonary angiography combined with echocardiography in suspected systemic sclerosis-associated pulmonary arterial hypertension.

Condliffe R, Radon M, Hurdman J, Davies C, Hill C, Akil M, Guarasci F, Rajaram S, Swift AJ, Wragg Z, van Beek E, Elliot CA, Kiely DG.

Rheumatology (Oxford). 2011 Aug;50(8):1480-6. doi: 10.1093/rheumatology/ker114. Epub 2011 Mar 29.

PMID:
21447566

Supplemental Content

Loading ...
Support Center